Robert W. Baird initiated coverage on BeyondSpring with a new price target
$BYSI
Biotechnology: Pharmaceutical Preparations
Health Care
Robert W. Baird initiated coverage of BeyondSpring with a rating of Outperform and set a new price target of $50.00